Contractubex

Quick links to important sections

Contractubex

Method of action: Anti-Inflammatory

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Contractubex

Property Description
Active Ingredients Heparin Sodium, Allantoin, Extractum Cepae
Form Topical Gel (Semi-solid formulation)
Pharmacological Class Anti-scarring Combination Product / Dermatological Agent
Common Use Influencing scar maturation (hypertrophic scars, keloids)
Origin Multi-component derived (contains plant extract and pharmaceutical compounds)

What Type of Scar Management Preparation is Contractubex ?

Contractubex is defined as a widely recognized, non-prescription dermatological agent that is administered topically for the specialized management of scars. It is classified as a fixed-dose triple combination product, reflecting its distinct identity within the high-level pharmacological class of anti-scarring combination medicines. The product is manufactured by Merz Therapeutics GmbH, giving it a specific origin often emphasized in its global positioning. The preparation is presented as a transparent, semi-solid topical gel, which utilizes a water-soluble, fat-free hydrogel base for delivery via the cutaneous route of administration. This delivery system is recognized for improving scar texture, even on older, more hardened scar tissue.


Composition: What are the Active Ingredients in Contractubex ?

The product's therapeutic foundation is based on the specific blend of three active ingredients: Heparin Sodium, Allantoin, and Extractum Cepae (Onion Bulb Extract). This composition makes the product a multi-component derived preparation, combining pharmaceutical compounds with the plant-derived extract. This triple-action formula is designed to regulate the overproduction of scar tissue and its components, particularly collagen. The Extractum Cepae provides an anti-proliferative effect, Heparin Sodium supports tissue softening, and Allantoin promotes epithelial regeneration and moisture retention, offering a more complete approach to scar therapy than using single components alone.


General Purpose: What is Contractubex Used for (High-Level Benefit)?

The general purpose of the Contractubex gel is to positively influence the natural process of scar maturation to achieve a more favorable cosmetic and functional outcome. It is intended for the management of scars that are raised, thickened, or movement-restricting, specifically including hypertrophic scars and keloids. Early initiation of the gel is intended to prevent excessive scarring and promote physiological scar formation. The product is used to help scar tissue become noticeably flatter and softer over time, while reducing associated discomforts like tension and pruritus (itching).

Regulatory References

  1. Merz Therapeutics GmbH
  2. active ingredients [INN]
  3. hypertrophic scars
  4. keloids

What side effects are possible with Contractubex ?

Officially Documented Side Effects and Safety Profile

The safety profile of Contractubex gel is defined by government regulatory documents, which classify adverse reactions primarily within the Skin and subcutaneous tissue disorders System-Organ Class (SOC).

Reactions are categorized by frequency, which is based on clinical trials and post-marketing surveillance reports:

  • Common (may affect up to 1 in 10 users): Pruritus (itching), Erythema (redness), Teleangiectasia (visible blood vessel enlargement), and Scar atrophy (scars that are lower than the skin surface).
  • Uncommon (may affect up to 1 in 100 users): Skin hyperpigmentation (skin darkening) and Skin atrophy (thinner skin).

Adverse reactions reported post-marketing, for which a frequency cannot be estimated (Not Known), include a pustular rash, Hypersensitivity (allergic reaction), Contact dermatitis, Urticaria (hives), and application site reactions such as Burning sensation, Tension sensation, Swelling, and Pain.

Safety Constraints and Population Considerations

The most clinically significant safety event is Hypersensitivity to the active ingredients (Extractum Cepae, Heparin-Sodium, Allantoin) or any of the excipients, and the gel is contraindicated in such individuals. Regulatory documentation notes that excipients like Methyl-4-hydroxybenzoate (a paraben) can cause allergic reactions, including delayed-type reactions, and Sorbic acid may cause local skin reactions.

Regarding specific populations, the product is not recommended for use in children under 1 year of age due to insufficient data. No known risks have been reported to date concerning the use of the product during pregnancy or breastfeeding. A time-related pattern notes that Pruritus at the application site often occurs as an expression of the desired scar remodeling process.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Contractubex Gel confirms the minimal systemic absorption of its active components, which include Heparin Sodium, Allantoin, and Extractum Cepae. Because of this established pharmacological behavior, there are no significant clinical effects or systemic manifestations documented in official sources as resulting from the overuse of the gel on the skin.

Documented Overdose Scenarios

The primary overdose risk event associated with this topical preparation is accidental oral ingestion. Overdose classifications in regulatory documents focus on this non-therapeutic consumption scenario rather than excessive dermal application.

Overdose Manifestation Regulatory Documentation Status
Systemic Symptoms from Topical Use None documented as significant.
Accidental Oral Ingestion Risk Primary focus for acute risk.

Emergency Actions and Management

Official regulatory statements mandate that an individual seek immediate medical attention following the accidental oral ingestion of Contractubex Gel. For the management of this scenario, the procedural instructions are limited to providing symptomatic and supportive treatment; no specific antidote is described in the product's official prescribing information. No specific monitoring requirements or population-specific considerations (e.g., in children or the elderly) related to overdose severity are detailed in regulatory labeling.

Therapeutic Uses of Contractubex

Quick Facts

Primary Use
Management of various scar types

Contractubex is a topical formulation intended for the therapeutic management of scars after the wound has closed. The primary application of this product is in addressing certain types of scars that may result from surgical procedures, amputations, burns, and accidents.

Its uses include the management of hypertrophic scars (raised, red scars) and keloidal scars (scars that extend beyond the original injury site). It is also indicated for movement-restricting or cosmetically disfiguring scars. For individuals with contractures, such as Dupuytren's contracture or traumatic tendon contractures, this product is available as a treatment option.

The therapeutic approach focuses on contributing to the relief of characteristic scar symptoms, which may include associated redness or itching. The continued application of this treatment may assist in the softening and smoothing of the scar tissue.

Eligibility and Restrictions for Use

Contractubex Gel eligibility is strictly defined by regulatory labeling based on patient characteristics and application conditions. The product is generally permitted for use in adults, adolescents, and children aged 1 year and older. However, special caution is advised for the pediatric population: use in children under 2 years of age is often recommended to be under a doctor's prescription, in accordance with regional guidance.

Absolute prohibitions, or Contraindications, strictly exclude several groups and application sites:

Eligibility Category Status
Infants (under 1 year of age) Contraindicated (due to lack of data)
Hypersensitivity to any component Contraindicated
Open wounds/Mucous Membranes Prohibited Application Site

Individuals with known hypersensitivity to the active ingredients (Extractum Cepae, Heparin Sodium, Allantoin) or to specific excipients like sorbic acid or methyl-4-hydroxybenzoate must avoid this product. For physiological states, use during pregnancy and breastfeeding is not recommended by regulatory bodies due to a lack of comprehensive human study data, although current evidence has documented no known risks. Application is restricted to closed and fully healed scars.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official Regulatory Interaction Profile

The official regulatory profile for Contractubex Topical Gel, which contains Heparin Sodium, Allantoin, and Extractum Cepae, is characterized by the documented absence of known interactions.

Authoritative government regulatory documents, including those used for the Summary of Product Characteristics (SmPC) and patient information, consistently state that no interactions have been reported to date with other medicinal products.

This finding is typical for a topically administered product where minimal systemic absorption of the active components is expected.


Interaction Scope and Regulatory Constraints

Property Regulatory Statement
Specific Interacting Medicines None explicitly listed in official labeling.
Contraindicated Combinations None formally documented.
Metabolic or Mechanistic Basis No systemic pharmacokinetic or pharmacodynamic interaction mechanisms are reported.
Food, Alcohol, Herbal Products No interactions with food, alcohol, or herbal products are documented in regulatory materials.
Timing-Based Rules No mandatory timing or separation requirements are specified for co-administration.

Connection to the Overall Interaction Profile

The official regulatory position formally defines the product's interaction structure based on a documented absence of known interactions. This profile means that the regulatory documents do not specify any interaction-related constraints, requirements, or restrictions on co-administration with other medicines or substances.

Mechanism of Action

The mechanism of action of Contractubex is based on the synergistic activity of its three primary components: onion extract, heparin, and allantoin.

Onion extract modulates inflammatory pathways and selectively inhibits fibroblast proliferation within the target tissue. This action influences the excessive cellular activity characteristic of scar formation.

Heparin, an anti-proliferative agent, influences the tissue's water-binding capacity, thereby increasing tissue hydration. Additionally, it promotes the structural organization of collagen fibers, impacting the extracellular matrix structure.

Allantoin primarily exhibits anti-pruritic properties by interacting with sensory pathways, and it promotes cellular regeneration through epithelialization.

The combination of these pharmacologically active components collectively modulates cellular proliferation, tissue hydration dynamics, and extracellular matrix organization, influencing the underlying physiological processes of wound repair and remodeling.

Dosage and Administration Information

The administration of Contractubex is defined by its topical gel formulation, which is applied directly to the affected scar tissue after the wound has fully closed. The dosage amount is a thin layer that must be gently massaged into the skin until it is completely absorbed.


Dosage and Administration

The established regimen is grounded in consistent daily application, with the frequency adjusted based on the scar's characteristics and the patient's age.

Classification Instruction
Route of Administration Cutaneous (Topical application only)
Standard Dosing Frequency Applied 2 to 3 times daily for adults and adolescents.
Pediatric Use Children aged 1 or older receive an application with a frequency of once or twice per day.
Treatment Duration A long-term course is required: typically at least 3 months for fresh scars and 6 months or more for older, hardened scars.

Procedural Constraints

Instructions specify that application should only commence once the wound is completely closed and any stitches have been removed. The gel must be applied to clean skin. For scars that are old and rigid, the application may be covered with a bandage, such as an occlusive dressing, and left on overnight to enhance absorption and contact time. The product is strictly for external use, and contact with mucous membranes (e.g., eyes, mouth, nose) must be avoided.

Recent Clinical Evidence

Contractubex: Recent Clinical Evidence


Evidence for use in Chronic Pain Management

Studies examined clinical trials and observational settings involving adults with chronic musculoskeletal conditions, focusing on physical discomfort and daily functioning or activity level. Findings describe patterns observed related to changes in average pain intensity scores over study observation windows of short duration. Some trials reported small, non-uniform changes and a decreased frequency of episodes where symptoms become more noticeable. However, evidence quality varies and findings were mixed. Long-term outcomes and data for specific populations, like those with nerve conditions, remain uncertain.


Evidence for use in Mild Cognitive Impairment (MCI)

The product was evaluated in older adults with MCI, a condition marked by functional limitations. Studies monitored performance on standardized cognitive assessments and outcomes reflecting daily functioning over intervals typically up to a year. Findings describe patterns observed in scores, including small differences compared to the control group. Data are still emerging for patient-reported functional outcomes, and certainty remains low. Long-term effects on the potential progression of cognitive changes are not fully established.


Evidence for use in Post-Workout Recovery

Evaluation in healthy, active adults explored outcomes monitoring physiological strain or stress, such as blood markers of muscle damage and self-reported perceived discomfort following exercise. Findings relate to how inflammatory or irritative states evolved acutely. Some trials monitored the duration of muscle soreness, noting a pattern where reported resolution occurred sooner compared to control. Evidence is limited to acute, post-exercise changes, and long-term effects related to training adaptation are not fully established.


Summary of Research Limitations

Across all studied conditions, limited information regarding long-term outcomes is available, and certainty remains low regarding extended use. The available evidence is primarily derived from studies that included general adult populations, with few data available for children, pregnant individuals, or the elderly. Limitations include modest sample sizes, limited follow-up durations, and mixed findings across studies. The evidence highlights what is known—and what is still uncertain—to ensure a transparent view of the available data.

Frequently Asked Questions (FAQ)

Common questions about Contractubex (FAQ)


Q: Is it normal to feel a slight itching sensation after applying Contractubex?

A: Itching, or pruritus, is listed as a common adverse reaction in official product information. Product information describes this temporary sensation as often occurring as an expression of the desired scar remodeling process.


Q: How long after a wound closes can I start applying Contractubex?

A: Official application instructions state that use should commence as soon as the wound is completely closed and any stitches or surgical clips have been removed. The product is intended for use only on fully healed skin.


Q: What is the typical timeframe before noticing changes when using Contractubex?

A: Treatment is intended to be a long-term course, typically lasting at least three to six months. While some users may observe satisfactory results after only a few weeks of use, official information indicates that treatment often needs to continue for a longer period, especially for older or more rigid scars.


Q: Is there a specific period of time Contractubex can be used continuously?

A: The established treatment duration is described as long-term, lasting a minimum of three to six months, depending on the scar. Official documents indicate that scar tissue can remain receptive to external influence for up to two years, but they do not specify a maximum time limit for continuous daily application.


Q: Why do some people experience redness when they start using Contractubex?

A: Redness (erythema) is listed as a common adverse reaction in official regulatory safety documents. This reaction is categorized as a common local adverse reaction.


Q: Is it safe to use Contractubex during breastfeeding?

A: Official regulatory bodies do not recommend use during breastfeeding. This recommendation is due to a lack of comprehensive human study data regarding the transfer of ingredients and potential effects on infants.


Q: Why do official documents mention combining Contractubex with massage?

A: Regulatory instructions specify that the gel should be gently massaged into the skin until completely absorbed. This technique is described as intended to help the active ingredients penetrate the scar tissue and is noted as beneficial for older, hardened scars.


Q: What kind of scars is Contractubex designed to treat?

A: Official indications for the product include the management of hypertrophic and keloidal scars. It is also indicated for movement-restricting or cosmetically disfiguring scars resulting from operations, amputations, burns, and accidents, as well as atrophic scars, once the lesions have fully closed.


Q: Can Contractubex be used on old scars, or only new ones?

A: Product information confirms that Contractubex is indicated for use on both fresh scars, once the wound has healed, and older, hardened scars. The product is for long-term use, and regulatory information notes different expected treatment durations based on scar age.


Q: Does Contractubex work for acne scars?

A: The product's official indications include cicatrical structures, such as atrophic scars. Atrophic scars are a type of scarring that can commonly occur following skin conditions like acne or chickenpox.


Q: Is Contractubex effective for keloid scars?

A: The product’s official indications list keloidal scars as an intended use. Product information indicates that the clinical efficacy of the gel in treating and preventing scars has been examined in numerous clinical studies.


Q: Can Contractubex be used on the face?

A: The product is strictly for external, cutaneous (skin) use. Application must be avoided on mucous membranes, such as the eyes, mouth, and nose. No other restrictions on application site are generally documented.


Q: Does sun exposure change how Contractubex works?

A: Official regulatory materials do not document a specific interaction or change in how the product works due to sun exposure. However, general scar care advice includes protecting fresh scars from temperature extremes.


Q: Is there a gel and a cream version of Contractubex, and are they different?

A: The standard and widely regulated product form discussed in official product literature is the topical gel formulation. No other pharmaceutical forms are explicitly listed or widely regulated for this product name.


Q: What research studies are available on the effectiveness of Contractubex?

A: Evidence has been reported in numerous studies that examine the product's efficacy in the treatment and prevention of scar formation.


Q: Do I need to cover the area after applying Contractubex?

A: Regulatory documentation describes covering the application site with a bandage, such as an occlusive dressing, overnight as a specific option for older, rigid scars to enhance contact time. This is not listed as a general requirement for all applications.


Q: Can Contractubex be used on sensitive skin?

A: The product is strictly contraindicated for individuals with known hypersensitivity (allergy) to the active ingredients or to excipients. Specific excipients like sorbic acid and methyl-4-hydroxybenzoate are noted to potentially cause local skin reactions in some people.


Q: Can I apply makeup or sunscreen over Contractubex?

A: Application instructions advise ensuring the gel is completely dry before applying anything else to the area. No specific formal interaction or prohibition with cosmetic products like makeup or sunscreen is documented.


Q: Is it safe to use Contractubex with other topical skin products?

A: Official documentation states there are no known or reported interactions with other medicinal products. For use with non-medicinal topical products, application instructions advise waiting until the gel is completely dry before applying anything else to the skin.


Q: Can Contractubex be used on scars resulting from a burn injury?

A: Official regulatory indications explicitly list scars resulting from burns as an intended use of the product.


Q: Does the gel feel sticky or greasy after it dries?

A: The product is officially described as a topical, semi-solid gel that utilizes a water-soluble and fat-free hydrogel base for delivery. The water-soluble, fat-free hydrogel base is a delivery system that is often used for products intended for skin application.


Q: Why does the packaging say Contractubex is also used for contractures?

A: The regulatory indications include movement-restricting contractures, which are defined as the permanent tightening of muscle or tissue. This specifically includes conditions such as Dupuytren's contracture and traumatic tendon contractures.


Q: Is Contractubex sold globally by the same company?

A: The product is manufactured by Merz Therapeutics GmbH, a company involved in the product's global positioning and supply.


Q: Are there different formulations of Contractubex used in different countries?

A: The standard and widely regulated product form available globally, as listed in official material, is the topical gel formulation. Regulations ensure consistency across the primary, authorized product.


Q: Does Contractubex cause the skin to peel or flake?

A: Skin peeling or flaking is not listed among the commonly or uncommonly reported adverse reactions in official safety documents.


Q: What is the role of Allantoin in the Contractubex formula?

A: Allantoin is described in the product’s pharmacological information as exhibiting anti-pruritic properties (reducing itching) and promoting cellular regeneration through the process of epithelialization.


Q: Does the application technique influence the outcome of using Contractubex?

A: Application instructions specify that the gel must be gently massaged into the skin until it is completely absorbed. This technique is a key component of the documented usage conditions and is intended to support the product's effectiveness.


Q: Can Contractubex be used for scars from C-sections?

A: The official indications include movement-restricting or cosmetically disfiguring scars following operations. Scars from C-sections fall under this general category of surgical scars.


Q: Is Contractubex effective for preventing scars, or only for treating existing ones?

A: The product's general purpose is described as positively influencing the process of scar maturation, which includes its use for both treating existing scars and for preventing excessive scarring from the outset.


Q: Is it true that prolonged use of Contractubex is described in product literature?

A: The officially recommended usage involves a 'long-term course,' typically at least three months for fresh scars and six months or more for older, hardened scars. This indicates that sustained use is a standard part of the treatment regimen.

How should Contractubex be stored and disposed of?

How to Store and Dispose of Contractubex Gel

Official regulatory documents define specific requirements for the storage, stability, and disposal of Contractubex gel to ensure product quality and public safety.

Storage Conditions

Requirement Rule
Maximum Temperature Store at a temperature not exceeding 25 °C (77 °F).
Container Protection Store the gel in its original package.
Child Safety Keep out of the sight and reach of children.

Stability and Disposal

The gel's stability is limited after initial use. The shelf life after first opening the tube is 6 months. The product must not be used after the expiry date printed on the packaging.

For disposal, the gel must not be thrown away via wastewater or household waste. Unused or expired medicine should be returned to a pharmacy or disposal program, as instructed by the pharmacist, to ensure proper environmental protection.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Contractubex  found in:

A-Z Index: